547. Deputy Cathal Crowe asked the Minister for Health when the rapid HTA, undertaken by HIQA in November 2022, reviewing the evidence of the clinical and cost-effectiveness of continuous (includes the Dexcom, Medtronic and GlucoRx CGMs) and intermittent (Freestyle Libre) glucose monitoring systems for people with type 1 diabetes will be published; and if it recommends the widening of access to these devices; and if funding will be provided to do so. [44911/23]

Summary

547. Deputy Cathal Crowe asked the Minister for Health when the rapid HTA, undertaken by HIQA in November 2022, reviewing the evidence of the clinical and cost-effectiveness of continuous (includes the Dexcom, Medtronic and GlucoRx CGMs) and intermittent (Freestyle Libre) glucose monitoring systems for people with type 1 diabetes will be published; and if it recommends the widening of access to these devices; and if funding will be provided to do so. [44911/23]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 17 October 2023

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.